Arctiin alleviates psoriasis-like dermatitis in association with gut microbiota remodeling and Akkermansia muciniphila enrichment
Introduction Psoriasis is a chronic recurrent inflammatory skin disease associated with gut microbiota dysbiosis. Arctiin (ARC), a plant-derived lignan, has anti-inflammatory and microbiota-modulating properties; however, its role in psoriasis remains unclear. Objective To investigate the protective effects of ARC against psoriasis-like dermatitis and the association between these effects and the gut microbiota. Methods Psoriasis-like dermatitis was induced in mice using topical imiquimod. ARC was administered prior to disease induction. Psoriasis-like inflammation was assessed by modified Psoriasis Area and Severity Index (mPASI) scoring, histopathology, immunofluorescence and RT–qPCR. The contribution of the gut microbiota was assessed using antibiotic treatment, fecal microbiota transplantation (FMT), and bacterial supplementation. The gut microbiota composition was analyzed by 16S rRNA gene sequencing. Results ARC markedly alleviated psoriasis-like inflammation, as evidenced by reduced mPASI scores, epidermal hyperplasia, immune cell infiltration and angiogenesis. ARC also decreased the expression of inflammatory mediators in psoriasis-like skin lesions. Antibiotic treatment attenuated the protective effects of ARC, whereas FMT from ARC-treated donors protected recipient mice. 16S rRNA sequencing revealed a reduced abundance of Akkermansia muciniphila (AKK) in psoriasis-like mice; the abundance was partially restored by ARC treatment. Supplementation with AKK partially recapitulated the protective effects of ARC, including the suppression of inflammatory cytokine expression and immune cell infiltration. Conclusion ARC alleviates psoriasis-like dermatitis through the modulation of the gut microbiota and the enrichment of AKK. These findings support a role for microbiota-associated mechanisms in ARC-mediated protection and highlight the potential of ARC as a microbiota-targeted therapeutic strategy for psoriasis.
Authors
- Wanchen Zhao (ORCID: https://orcid.org/0009-0003-3952-387X)
- François Niyonsaba (ORCID: https://orcid.org/0000-0002-0588-8315)
- Hideoki Ogawa (ORCID: https://orcid.org/0000-0003-4268-8790)
- Alafate Abudouwanli (ORCID: https://orcid.org/0009-0006-9427-8258)
- Ko Okumura
- Xinghua Gao
- Yi Tan
- Shan Wang
- Quan Sun
- Ge Peng
- Mengyao Yang
Institutions
- Juntendo University (JP)
- First Hospital of China Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fimmu.2026.1954060
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Education, Culture, Sports, Science and Technology